Slovenia suspends Johnson vaccine over death of 20-year-old

By | September 29, 2021

Slovenia has suspended Johnson & Johnson jabs while probing the death of a 20-year-old woman as thousands are expected at a protest against vaccination in the small European Union nation

LJUBLJANA, Slovenia — Slovenia on Wednesday suspended vaccinations with the Johnson & Johnson coronavirus jab while it probes the death of a 20-year-old woman, as thousands started gathering for a protest against vaccination in the small European Union nation.

The suspension will be in place until experts examine whether there is a link between the woman’s death from a stroke and the vaccine she had received two weeks earlier, said Health Minister Janez Poklukar.

The one-dose jabs have grown in popularity in recent weeks in Slovenia after authorities widely introduced COVID passes, including for going to work in all state-run firms. The government has approved the purchase of an additional 100,000 J&J doses from Hungary in response to the growing demand.

The woman’s death this week was the second serious case of adverse effects of the Johnson & Johnson jabs that have been administered to about 120,000 people in Slovenia, the official STA news agency reported.

However, “benefits continue to outweigh the risks,” Poklukar said.

Still, the announcement is likely to fuel Wednesday’s protests planned in the capital, Ljubljana, against vaccination and coronavirus measures.

Previous similar protests have drawn thousands, and demonstrators recently clashed with police. Ahead of Wednesday’s rally, police put up metal fences and urged participants to remain calm.

Read More:  Boris Johnson hints MORE countries could be added to amber and red travel list

Like much of Central and Eastern Europe, Slovenia in recent weeks has seen a rise in infections. The country of some 2 million people has fully vaccinated nearly 48% of the population, which is lower than in many other EU states.

Slovenia has recommended Johnson & Johnson vaccines to all people over 18 years old, unlike some countries who have limited its use to older people.

ABC News: Health